Drug intelligence / Profile preview

Shen Bai Ning Shen Oral Liquid

Development stage: Unknown
Lead developer: Zhejiang Kangde Pharmaceutical
Administration: Oral

Overview

Shen Bai Ning Shen Oral Liquid is a traditional Chinese medicine (TCM) formulation developed and manufactured by Zhejiang Kangde Pharmaceutical. It is specifically formulated to tonify qi and yin and to calm the nerves (Ningshen). The product is indicated for the treatment of symptoms associated with qi and yin deficiency, including nervousness, restlessness, and sleep-related disturbances such as insomnia. As an oral liquid preparation, it utilizes a blend of botanical extracts traditionally recognized in Chinese pharmacopeia for their adaptogenic and sedative properties. The drug is currently approved and marketed in China for these indications.

Brand names: Shen Bai Ning Shen Oral Liquid
Other names: Shenbai Ningshen Oral Liquid

Beyond the preview

Go deeper on Shen Bai Ning Shen Oral Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shen Bai Ning Shen Oral Liquid.

Explore the full profile